Riskpilot← Back to searchSign inGet full accessAdesso BioComponents AB
ABActiveOrg 5592269145Economic activity was not specified by tax authority · NACE 0000Est. 20190 employees
Revenue 2024
SEK 0
EBITDA margin
—
-50% vs 2023
Equity ratio
80.4%
Financial strength
Net profit 2024
SEK -9K
-105% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -9K | -50% |
| Net profit | SEK -9K | -105% |
| Total assets | SEK 250K | -2% |
| Equity | SEK 201K | -4% |
| Employees | 0 | — |
Legal name
Adesso BioComponents AB
Org number
5592269145
Legal form
Aktiebolag
NACE code
0000 · Economic activity was not specified by tax authority
Founded
15 november 2019
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget skall ha till föremål för sin verksamhet att framställa, lagra, distribuera, sälja och marknadsföra kemiprodukter från biobaserade råvaror samt förvärva och äga mark och fastigheter för detta ändamål. Vidare skall företaget förvärva respektive sälja teknologi, licenser och immateriella tillgångar inom dessa områden samt annan därmed förenlig verksamhet.
Address
Email
roger@adessobygg.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | — | −1 | −9 | −6 | −9 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 0 | −1 | −9 | −6 | −9 |
| Net financials | — | — | — | — | — |
| Profit before tax | 0 | −1 | −9 | 214 | −9 |
| Tax | −0 | −0 | −0 | −44 | −0 |
| Net profit | 0 | −1 | −9 | 170 | −9 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 50 | 49 | 40 | 254 | 250 |
| Equity | 50 | 49 | 40 | 210 | 201 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 0 | 0 | 0 | 44 | 48 |
| Total debt | — | — | — | 44 | 48 |
EBITDA margin
-900000.0%
This company
15.8%
Market median
-5696303% vs market
20202024
Equity ratio
80.4%
This company
38.2%
Market median
+110% vs market
20202024
Return on equity
-4.5%
This company
18.4%
Market median
-124% vs market
20202024
Net profit margin
-900000.0%
This company
8.1%
Market median
-11111211% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.24×
This company
0.62×
Market median
+61% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-11-01 – 2020-08-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2022 | — | — | |
| Deputy Board Member | 2022 | — | — | |
| Board of Directors | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Adesso Greentech AB | Company | 100.0% | 100.0% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Adesso Green Holding AB
Adesso BioComponents AB Board members of Adesso BioComponents AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars-Erik Roger Andersen | Chairman | 0 companies |
| Nic Daniel Larson | Deputy Board Member | 0 companies |
| Lars-Olof Lind | Board of Directors | 0 companies |